TY - JOUR
T1 - Cell-free synthetic biology
T2 - Thinking outside the cell
AU - Hodgman, C. Eric
AU - Jewett, Michael C.
N1 - Funding Information:
The authors thank B. Fritz, A. Hockenberry, and L. Timmerman for advice and discussions. We also gratefully acknowledge funding from the National Institutes of Health (Grant number R00GM081450 ), the National Academies Keck Futures Initiative (Grant number NAFKI-SB5 ), the National Science Foundation (Grant number MCB-0943393 ), the DARPA YFA Program (Grant number N66001-11-1-4137 ), and the Office of Naval Research (Grant number N00014-11-1-0363 ).
PY - 2012/5
Y1 - 2012/5
N2 - Cell-free synthetic biology is emerging as a powerful approach aimed to understand, harness, and expand the capabilities of natural biological systems without using intact cells. Cell-free systems bypass cell walls and remove genetic regulation to enable direct access to the inner workings of the cell. The unprecedented level of control and freedom of design, relative to . in vivo systems, has inspired the rapid development of engineering foundations for cell-free systems in recent years. These efforts have led to programmed circuits, spatially organized pathways, co-activated catalytic ensembles, rational optimization of synthetic multi-enzyme pathways, and linear scalability from the micro-liter to the 100-liter scale. It is now clear that cell-free systems offer a versatile test-bed for understanding why nature's designs work the way they do and also for enabling biosynthetic routes to novel chemicals, sustainable fuels, and new classes of tunable materials. While challenges remain, the emergence of cell-free systems is poised to open the way to novel products that until now have been impractical, if not impossible, to produce by other means.
AB - Cell-free synthetic biology is emerging as a powerful approach aimed to understand, harness, and expand the capabilities of natural biological systems without using intact cells. Cell-free systems bypass cell walls and remove genetic regulation to enable direct access to the inner workings of the cell. The unprecedented level of control and freedom of design, relative to . in vivo systems, has inspired the rapid development of engineering foundations for cell-free systems in recent years. These efforts have led to programmed circuits, spatially organized pathways, co-activated catalytic ensembles, rational optimization of synthetic multi-enzyme pathways, and linear scalability from the micro-liter to the 100-liter scale. It is now clear that cell-free systems offer a versatile test-bed for understanding why nature's designs work the way they do and also for enabling biosynthetic routes to novel chemicals, sustainable fuels, and new classes of tunable materials. While challenges remain, the emergence of cell-free systems is poised to open the way to novel products that until now have been impractical, if not impossible, to produce by other means.
KW - Biocatalysis
KW - Cell-free biology
KW - In vitro protein synthesis
KW - Metabolic engineering
KW - Synthetic biology
KW - Synthetic enzymatic pathways
UR - http://www.scopus.com/inward/record.url?scp=83255164998&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=83255164998&partnerID=8YFLogxK
U2 - 10.1016/j.ymben.2011.09.002
DO - 10.1016/j.ymben.2011.09.002
M3 - Article
C2 - 21946161
AN - SCOPUS:83255164998
SN - 1096-7176
VL - 14
SP - 261
EP - 269
JO - Metabolic Engineering
JF - Metabolic Engineering
IS - 3
ER -